ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling

Pan, Linyu; Yu, Ze; Liang, Xiaolin; Yao, Jiyou; Fu, Yanfang; He, Xu; Ren, Xiaoling; Chen, Jiajia; Li, Xuejuan; Lu, Minqiang*; Lan, Tian*广东药学院; 中国医科大学; 1
Hepatology Communications2023-2DOI: 10.1097/HC9.0000000000000039
17阅读
引用收藏
分享

摘要

Non-alcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. The gut-liver axis is a potential therapy for NASH. Sodium cholate (SC) is a choleretic drug whose main component is bile acids and has anti-inflammatory, antifibrotic, and hepatoprotective effects. This study aimed to investigate whether SC exerts anti-NASH effects by the gut-liver axis. Mice were fed with an high-fat and high-cholesterol (HFHC) diet for 20 weeks to induce NASH. Mice were daily intragastric administrated with SC since the 11th week after initiation of HFHC feeding. The toxic effects of SC on normal hepatocytes were determined by CCK8 assay. The lipid accumulation in hepatocytes was virtualized by Oil Red O staining. The mRNA levels of genes were determined by real-time quantitative PCR assay. SC alleviated hepatic injury, abnormal cholesterol synthesis, and hepatic steatosis and improved serum lipid profile in NASH mice. In addition, SC decreased HFHC-induced hepatic inflammatory cell infiltration and collagen deposition. The target protein-protein interaction network was established through Cytoscape software, and NR1H4 [farnesoid x receptor (FXR)] was identified as a potential target gene for SC treatment in NASH mice. SCactivated hepatic FXR and inhibited CYP7A1 expression to reduce the levels of bile acid. In addition, high-dose SC attenuated the abnormal expression of cancer markers in NASH mouse liver. Finally, SC significantly increased the expression of FXR and FGF15 in NASH mouse intestine. Taken together, SC ameliorates steatosis, inflammation, and fibrosis in NASH mice by activating hepatic and intestinal FXR signaling so as to suppress the levels of bile acid in NASH mouse liver and intestine.

学科与关键词

关键词
FATTY LIVER-DISEASERECEPTOR FXRADIPOSE-TISSUEACIDMECHANISMSPATHWAYSOBESITYMICE
相关
加载中…
  • Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline-Deficient (MCD) Diet-induced Nonalcoholic Steatohepatitis (NASH) Mice
    Xiong, Fei; Zheng, Zhongdaixi; Xiao, Lingyu; Su, Chuhong; Chen, Junbin; Gu, Xiangfu; Tang, Jiaqi; Zhao, Yue; Luo, Huiyu; Zha, Longying*Molecular Nutrition and Food Research, 2021, 65(14): 2100067.被引 18
  • Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
    Kuang, Junliang; Wang, Jieyi; Li, Yitao; Li, Mengci; Zhao, Mingliang; Ge, Kun; Zheng, Dan; Cheung, Kenneth C. P.; Liao, Boya; Wang, Shouli; Chen, Tianlu; Zhang, Yinan; Wang, Congrong; Ji, Guang; Chen, Peng; Zhou, Hongwei; Xie, Cen; Zhao, Aihua; Jia, Weiping*; Zheng, Xiaojiao*; Jia, WeiCell Metabolism, 2023, 35(10): 1752-+.被引 7
  • Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
    Lin, Chuangzhen; Yu, Bingqing; Chen, Lixin; Zhang, Zhaohui; Ye, Weixiang; Zhong, Hui; Bai, Wenke; Yang, Yuping; Nie, Biao*Frontiers in Pharmacology, 2022, 13: 880508.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology Communications
发表日期
2023-02
卷期
第 7 卷, 第 2 期
页码
e0039
DOI
10.1097/HC9.0000000000000039
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81870420, 82070590]; Joint Key Project of City and Hospital of Guangzhou Science and Technology Planning

作者

  • P

    Pan, Linyu (第一作者)

    guangdong pharmaceut univ

  • Y

    Yu, Ze

    guangdong pharmaceut univ

查看全部 11 位作者收起作者
  • L

    Liang, Xiaolin

    guangdong pharmaceut univ

  • Y

    Yao, Jiyou

    2

  • F

    Fu, Yanfang

    guangdong pharmaceut univ

  • H

    He, Xu

    guangdong pharmaceut univ

  • R

    Ren, Xiaoling

    guangdong pharmaceut univ

  • C

    Chen, Jiajia

    guangdong pharmaceut univ

  • L

    Li, Xuejuan

    china med univ · shenzhen childrens hosp

  • L

    Lu, Minqiang (通讯)

    1 · 2

  • L

    Lan, Tian (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417